Fellowship · Los Angeles, CA
Sponsored by Cedars-Sinai Medical Center
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study.
Lancet (London, England) · 2024 · 686 citations · Mark Faries
Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2021 · 1,081 citations · Cristina Ferrone
Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma.
The New England journal of medicine · 2024 · 438 citations · Mark Faries
Assessing the Accuracy of Responses by the Language Model ChatGPT to Questions Regarding Bariatric Surgery.
Obesity surgery · 2023 · 209 citations · Miguel Burch
Neoadjuvant therapy for pancreatic cancer.
Nature reviews. Clinical oncology · 2023 · 321 citations · Cristina Ferrone
Recent advances in the management of hepatocellular carcinoma.
Clinical and molecular hepatology · 2024 · 140 citations · Kambiz Kosari, Nicholas Nissen
Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical Trial.
JAMA · 2025 · 74 citations · Armando Giuliano
Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment.
Nature genetics · 2022 · 341 citations · Cristina Ferrone